{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:04:59Z","timestamp":1784909099701,"version":"3.55.0"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"DOI":"10.7759\/cureus.113305","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:18:03Z","timestamp":1784906283000},"source":"Crossref","is-referenced-by-count":0,"title":["Immunohistochemical Study of p53 and Ki-67 in Benign and Malignant Prostatic Lesions"],"prefix":"10.7759","author":[{"given":"Ayushi","family":"Shrivastava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijayalaxmi","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.14740\/wjon1191","article-title":"Epidemiology of prostate cancer","volume":"10","author":"Rawla P","year":"2019","unstructured":"Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019, 10:63-89. 10.14740\/wjon1191","journal-title":"World J Oncol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","article-title":"Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches","volume":"27","author":"Sekhoacha M","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P, Gumenku L, Adegoke A, Mashele S. Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecules. 2022, 27:5730. 10.3390\/molecules27175730","journal-title":"Molecules"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pros.2990150506","article-title":"Etiology and disease process of benign prostatic hyperplasia","volume":"2","author":"Isaacs JT","year":"1989","unstructured":"Isaacs JT, Coffey DS. Etiology and disease process of benign prostatic hyperplasia. Prostate Suppl. 1989, 2:33-50. 10.1002\/pros.2990150506","journal-title":"Prostate Suppl"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-08-0043","article-title":"Endocrine disruptors and prostate cancer risk","volume":"15","author":"Prins GS","year":"2008","unstructured":"Prins GS. Endocrine disruptors and prostate cancer risk. Endocr Relat Cancer. 2008, 15:649-656. 10.1677\/ERC-08-0043","journal-title":"Endocr Relat Cancer"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajur.2018.11.007","article-title":"Diagnosis of prostate cancer","volume":"6","author":"Descotes JL","year":"2019","unstructured":"Descotes JL. Diagnosis of prostate cancer. Asian J Urol. 2019, 6:129-136. 10.1016\/j.ajur.2018.11.007","journal-title":"Asian J Urol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2020-0015-RA","article-title":"The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer","volume":"145","author":"Epstein JI","year":"2021","unstructured":"Epstein JI, Amin MB, Fine SW, et al.. The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer. Arch Pathol Lab Med. 2021, 145:461-493. 10.5858\/arpa.2020-0015-RA","journal-title":"Arch Pathol Lab Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.10.025","article-title":"The molecular taxonomy of primary prostate cancer","volume":"163","year":"2015","unstructured":"The molecular taxonomy of primary prostate cancer. Cell. 2015, 163.1011-1025. 10.1016\/j.cell.2015.10.025","journal-title":"Cell"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/419348","article-title":"Preclinical remodeling of human prostate cancer through the PTEN\/AKT pathway","volume":"2012","author":"De Velasco MA","year":"2012","unstructured":"De Velasco MA, Uemura H. Preclinical remodeling of human prostate cancer through the PTEN\/AKT pathway. Adv Urol. 2012, 2012:419348. 10.1155\/2012\/419348","journal-title":"Adv Urol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.607670","article-title":"Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches","volume":"8","author":"Alvarado-Ortiz E","year":"2021","unstructured":"Alvarado-Ortiz E, de la Cruz-L\u00f3pez KG, Becerril-Rico J, Sarabia-S\u00e1nchez MA, Ortiz-S\u00e1nchez E, Garc\u00eda-Carranc\u00e1 A. Mutant p53 gain-of-function: role in cancer development, progression, and therapeutic approaches. Front Cell Dev Biol. 2021, 8:607670. 10.3389\/fcell.2020.607670","journal-title":"Front Cell Dev Biol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)35458-7","article-title":"p53 gene alterations in human prostate carcinoma","volume":"150","author":"Effert PJ","year":"1993","unstructured":"Effert PJ, McCoy RH, Walther PJ, Liu ET. p53 gene alterations in human prostate carcinoma. J Urol. 1993, 150:257-261. 10.1016\/s0022-5347(17)35458-7","journal-title":"J Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410x.1992.tb15632.x","article-title":"P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia","volume":"69","author":"Thompson SJ","year":"1992","unstructured":"Thompson SJ, Mellon K, Charlton RG, Marsh C, Robinson M, Neal DE. P53 and Ki-67 immunoreactivity in human prostate cancer and benign hyperplasia. Br J Urol. 1992, 69:609-613. 10.1111\/j.1464-410x.1992.tb15632.x","journal-title":"Br J Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7796.158507","article-title":"Significance of p53 and ki-67 expression in prostate cancer","volume":"7","author":"Verma R","year":"2015","unstructured":"Verma R, Gupta V, Singh J, et al.. Significance of p53 and ki-67 expression in prostate cancer. Urol Ann. 2015, 7:488-493. 10.4103\/0974-7796.158507","journal-title":"Urol Ann"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.18231\/j.ijpo.2022.015","article-title":"Clinicopathological correlation of p53 expression in benign prostatic hyperplasia and prostate adenocarcinoma","volume":"9","author":"Bhat G","year":"2022","unstructured":"Bhat G, Afroz Ahamed M, Saroha N, Prasad G. Clinicopathological correlation of p53 expression in benign prostatic hyperplasia and prostate adenocarcinoma. Indian J Pathol Oncol. 2022, 9:60-64. 10.18231\/j.ijpo.2022.015","journal-title":"Indian J Pathol Oncol"},{"key":"ref14","article-title":"Expression of Ki-67 in prostate cancers and its correlation with histopathological grade and serum prostate-specific antigen (PSA) levels: a study from eastern part of Uttar Pradesh","volume":"8","author":"Gangwar S","year":"2020","unstructured":"Gangwar S, Shukla P, Singh V, Pandey P. Expression of Ki-67 in prostate cancers and its correlation with histopathological grade and serum prostate-specific antigen (PSA) levels: a study from eastern part of Uttar Pradesh. J Med Sci Clin Res. 2020, 8:295-302.","journal-title":"J Med Sci Clin Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.5958\/2394-6792.2016.00019.3","article-title":"Ki67 as a prognostic marker in comparison with Gleason\u2019s grading system in prostatic carcinoma","volume":"3","author":"Rajeswari K","year":"2016","unstructured":"Rajeswari K, Meenakshisundaram K, Anushuya G, Rajalakshmi V. Ki67 as a prognostic marker in comparison with Gleason\u2019s grading system in prostatic carcinoma. Indian J Pathol Oncol. 2016, 3:92-95. 10.5958\/2394-6792.2016.00019.3","journal-title":"Indian J Pathol Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.4081\/816","article-title":"Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation","volume":"47","author":"Mu\u00f1oz E","year":"2003","unstructured":"Mu\u00f1oz E, G\u00f3mez F, Paz JI, Casado I, Silva JM, Corcuera MT, Alonso MJ. Ki-67 immunolabeling in pre-malignant lesions and carcinoma of the prostate. Histological correlation and prognostic evaluation. Eur J Histochem. 2003, 47:123-128. 10.4081\/816","journal-title":"Eur J Histochem"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/515173-immunohistochemical-study-of-p53-and-ki-67-in-benign-and-malignant-prostatic-lesions","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T15:18:03Z","timestamp":1784906283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/515173-immunohistochemical-study-of-p53-and-ki-67-in-benign-and-malignant-prostatic-lesions"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":16,"URL":"https:\/\/doi.org\/10.7759\/cureus.113305","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,24]]}}}